Balyasny Asset Management
VANI icon

Balyasny Asset Management’s Vivani Medical VANI Stock Holding History

Balyasny Asset Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,346
Closed -$54K – 2059
2018
Q2 		$54K Sell
1,346
-2,212
-62% -$96.3K ﹤0.01% 1733
2018
Q1 		$164K Buy
3,558
+641
+22% +$28.5K ﹤0.01% 1788
2017
Q4 		$134K Buy
+2,917
New +$96.9K ﹤0.01% 1958
2016
Q2 		– Sell
-560
Closed -$65K – 1467
2016
Q1 		$65K Buy
+560
New +$64.4K ﹤0.01% 1222

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $85.5M AUM 3.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management's VANI Position: Q3 2018 in Review

Balyasny Asset Management sold out of Vivani Medical (VANI) in Q3 2018, closing a stake of 1,346 shares — an estimated $54K sold.

Balyasny Asset Management first reported a position in VANI in Q1 2016 and held it in 4 quarters. The position peaked at $164K in Q1 2018. 44 funds tracked by Wall St. Rank hold VANI as of Q3 2018.

  • Balyasny Asset Management reported no remaining Vivani Medical position as of Q3 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 1,346 Vivani Medical shares in Q3 2018, an estimated $54K.
  • Balyasny Asset Management first reported a position in Vivani Medical in Q1 2016 and held it in 4 quarters.
  • Balyasny Asset Management's Vivani Medical position peaked at $164K in Q1 2018.
  • 44 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.